Event-Driven Stocks

Streamex Corp.

STEXNasdaq

Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs2 good1 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$40,000$18,000$286,000$441,000$0
Operating income−$71.1M−$12.9M−$28.5M−$27.3M−$33.4M−$59.2M
Net income−$462.8M−$10.3M−$29.0M−$27.1M−$31.9M−$52.2M
Total assets$187.5M$842,000$1.8M$4.1M$15.5M$30.4M
Total liabilities$54.2M$2.3M$4.7M$3.7M$3.0M$5.1M
Equity$133.2M−$1.5M−$3.0M$313,000$12.2M$24.4M
EPS (diluted)$-9.65$-0.75$-3.95$-6.33
Shares out.24.3M11.2M66.9M38.4M31.8M26.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
Net margin
Return on equity
−347.5%
Return on assets
−246.8%
Return on capital (ROCE)
−49.1%
Liabilities / assets
28.9%
Debt / equity
0.41×
Book value / share
$5.49
Revenue growth (YoY)
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-11.43distress
Accruals / assets
241.2%clean
Piotroski F-Score
4/7mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
61
/ 100
Profitability 0Growth n/aCatalyst 100Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe1 warning2 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
11 acquisitions1 disposals6 open-market buy(s)net +4.2M shares · last 12
InsiderDateTypeSharesPrice
Lekstrom Morgan LeeOfficer — Interim Executive ChairmanMay 28, 2026Buy34,000$1.47
Marciano Anthony MarkDirectorMay 21, 2026Buy17,745.142$1.13
Lekstrom Morgan LeeOfficer — Interim Executive ChairmanMay 21, 2026Buy41,048$1.02
Williams Mitchell YoungOfficer — Chief Investment OfficerApr 28, 2026Grant2.3M$0.00
Lekstrom Morgan LeeOfficer — Interim Executive ChairmanJan 8, 2026Grant100,000$0.00
Mcphie Karl Henry MichaelOfficer — CEOJan 8, 2026Grant1.0M$0.00
Plummer Christine MarieOfficer — Chief Financial OfficerApr 13, 2026Sell10,922$1.10
Plummer Christine MarieOfficer — Chief Financial OfficerMar 16, 2026Grant500,000$0.00
Marciano Anthony MarkDirectorFeb 23, 2026Grant100,000$0.00
Lekstrom Morgan LeeOfficer — Executive ChairmanFeb 18, 2026Buy20,000$2.50
Giustra Frank10% ownerFeb 4, 2026Buy100,000$3.17
Lekstrom Morgan LeeDirectorFeb 3, 2026Buy23,500$3.06

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20266.6M4.4-1.9%
Apr 30, 20266.7M5.1+6.9%
Apr 15, 20266.3M4.4+16.1%
Mar 31, 20265.4M2.1+7.1%
Mar 13, 20265.0M4.1+1.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗
  • 4/AMay 28, 2026
  • 4/AMay 28, 2026
  • 8-KMay 28, 2026
  • 4May 28, 2026
  • 8-KMay 27, 2026
  • 4May 22, 2026
  • 4May 21, 2026
  • 10-QMay 14, 2026
  • 4May 4, 2026
  • 8-KMay 4, 2026
  • 4Apr 17, 2026
  • 4Apr 17, 2026
  • 4Apr 17, 2026
  • 8-KApr 10, 2026
  • 10-KMar 31, 2026

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.